Risultati per: Prima terapia farmacologica per l’apnea notturna (OSAS)

A crescere di più sono le spese a carico di malati e famiglie

Utilizza un coniugato anticorpo-farmaco anti cellule tumorali

Finora tra 6 regioni prive. Il contributo del ‘Progetto Noemi’

La Commissione europea ha concesso il trasferimento alla Fondazione dell’autorizzazione all’immissione in commercio della terapia genica per l’immunodeficienza Ada-Scid. È la prima volta al mondo

Una bimba palestinese la prima curata con terapia genica

Research has tied obstructive sleep apnea to an increased risk of cardiovascular disease and death. So far, though, the mechanism underlying the association has been unclear.

Esperimento alla Cleveland Clinic, allevia preoccupazioni

Gli operatori: “Reazione sorprendente” con la bambola iconica

Gli operatori: “Reazione sorprendente” con la bambola iconica

Studio, 5 minuti in più scoprono pazienti a rischio effetti collaterali

Stroke, Ahead of Print.

Stroke, Ahead of Print. BACKGROUND:The aim of this study was to characterize change in sleep-disordered breathing severity in the year following stroke, overall, and by ethnicity, within the population-based Brain Attack Surveillance in Corpus Christi Project.METHODS:First-ever ischemic strokes (n=414) were ascertained by active and passive surveillance and validated by stroke-trained physicians. Patients with stroke were invited to participate in portable sleep apnea testing (ApneaLink Plus) at baseline and 3, 6, and 12 months poststroke. Sleep-disordered breathing severity was assessed by the respiratory event index (apneas and hypopneas/hour of recording). The component obstructive apnea index and central apnea index were also assessed. Time and ethnicity effects on outcomes, as well as ethnic differences in time effects, were analyzed using generalized estimating equations with multivariable adjustment for confounding factors.RESULTS:Mean age (n=414) was 63.9 years (SD=10.9); 68.4% were Mexican American. Baseline mean respiratory event index, obstructive apnea index, and central apnea index were 21.3 (SD=16.6), 8.6 (SD=11.5), and 1.5 (SD=3.2), respectively. There was no time effect on respiratory event index (P=0.35) but obstructive apnea index increased over time (P

La probabilità sale con gli anni di uso, studio

La probabilità sale con gli anni di uso, studio